A 12-week, Multi-center, Randomized, Double-blind, Placebo-Controlled Clinical Trial for the Evaluation of the Efficacy and Safety of HUN2-483 on Cognitive Function Improvement
- Conditions
- Mental and behavioural disorders
- Registration Number
- KCT0009401
- Lead Sponsor
- Huons
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 100
1) Adult aged 40 to under 85
2) Koreans who can decipher Korean language
3) Participants who have mini mental state examination score of 18 to 28
4) A person who agrees to participate in this study before the start of the study and prepares a written consent form
1) A person currently being treated for severe cardiovascular, respiratory, immune, gastrointestinal/hepatic and biliary systems, kidney and urology, nervous, musculoskeletal, infectious diseases and malignant tumors
2) A Persons who has neuropsychological disease such as depression (based on DSM-5), schizophrenia, alcoholism, and drug dependence
3) A person who has a disease accompanied by cognitive impairment, such as dementia (based on DSM-5) and Parkinson's disease
4) A person diagnosed with an intellectual disability
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Alzheimer's Disease Assessment Scale-cognitive subscale
- Secondary Outcome Measures
Name Time Method Visual C.P.T;Korean Mini-Mental Status Examination;Korean-Beck Depression Inventory-II;Stroop test;Brain-derived neurotrophic factor